These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
295 related items for PubMed ID: 11211610
1. Cellular dyscohesion in fine-needle aspiration of breast carcinoma. Prognostic indicator for axillary lymph node metastases? Schiller AB, Tadros TS, Birdsong GG, Grossl NA. Am J Clin Pathol; 2001 Feb; 115(2):219-23. PubMed ID: 11211610 [Abstract] [Full Text] [Related]
2. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation. Alkuwari E, Auger M. Cancer; 2008 Apr 25; 114(2):89-93. PubMed ID: 18286535 [Abstract] [Full Text] [Related]
3. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, Lee JH, Kang SS, Lee JE, Kang MK, Park YJ, Nam HR. Jpn J Clin Oncol; 2005 Mar 25; 35(3):126-33. PubMed ID: 15741302 [Abstract] [Full Text] [Related]
4. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Barth A, Craig PH, Silverstein MJ. Cancer; 1997 May 15; 79(10):1918-22. PubMed ID: 9149018 [Abstract] [Full Text] [Related]
5. Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma. Durak MG, Akansu B, Akin MM, Sevınç AI, Koçdor MA, Saydam S, Harmancioğlu O, Ellıdokuz H, Bekış R, Canda T. Turk Patoloji Derg; 2011 May 15; 27(3):189-95. PubMed ID: 21935867 [Abstract] [Full Text] [Related]
6. Factors that predict the burden of axillary disease in breast cancer patients with a positive sentinel node. Beriwal S, Soran A, Kocer B, Wilson JW, Ahrendt GM, Johnson R. Am J Clin Oncol; 2008 Feb 15; 31(1):34-8. PubMed ID: 18376225 [Abstract] [Full Text] [Related]
7. Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective study. Classe JM, Loussouarn D, Campion L, Fiche M, Curtet C, Dravet F, Pioud R, Rousseau C, Resche I, Sagan C. Cancer; 2004 Mar 01; 100(5):935-41. PubMed ID: 14983488 [Abstract] [Full Text] [Related]
8. Micrometastatic sentinel lymph node disease: do patients benefit or suffer harm from axillary lymph node dissection? Ziogas D, Zografos GC. Ann Surg Oncol; 2010 Mar 01; 17(3):936-7; author reply 938. PubMed ID: 19937389 [No Abstract] [Full Text] [Related]
9. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Krishnamurthy S, Sneige N, Bedi DG, Edieken BS, Fornage BD, Kuerer HM, Singletary SE, Hunt KK. Cancer; 2002 Sep 01; 95(5):982-8. PubMed ID: 12209680 [Abstract] [Full Text] [Related]
10. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature. Witt A, Obwegeser R, Auerbach L, Tempfer C, Yavuz D, Kubista E. Wien Klin Wochenschr; 2002 Jun 14; 114(10-11):387-90. PubMed ID: 12708092 [Abstract] [Full Text] [Related]
11. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis. Joseph KA, El-Tamer M, Komenaka I, Troxel A, Ditkoff BA, Schnabel F. Arch Surg; 2004 Jun 14; 139(6):648-51. PubMed ID: 15197092 [Abstract] [Full Text] [Related]
12. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study. Unal B, Gur AS, Beriwal S, Tang G, Johnson R, Ahrendt G, Bonaventura M, Soran A. Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):1035-40. PubMed ID: 19327916 [Abstract] [Full Text] [Related]
13. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy. Meijnen P, Oldenburg HS, Loo CE, Nieweg OE, Peterse JL, Rutgers EJ. Br J Surg; 2007 Aug 15; 94(8):952-6. PubMed ID: 17440955 [Abstract] [Full Text] [Related]
14. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer. Escobar PF, Patrick RJ, Rybicki LA, Hicks D, Weng DE, Crowe JP. Ann Surg Oncol; 2006 Jun 15; 13(6):783-7. PubMed ID: 16604475 [Abstract] [Full Text] [Related]
15. Clinical importance of preoperative detection of the apical lymph node metastasis in patients with breast carcinoma. Güven HE, Bulak H, Turanli S, Oral S. Singapore Med J; 2007 Jan 15; 48(1):31-3. PubMed ID: 17245513 [Abstract] [Full Text] [Related]
16. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Truong PT, Olivotto IA, Kader HA, Panades M, Speers CH, Berthelet E. Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1337-47. PubMed ID: 15817335 [Abstract] [Full Text] [Related]
17. Tumour size as a predictor of axillary node metastases in patients with breast cancer. Laura S, Coombs NJ, Ung O, Boyages J. ANZ J Surg; 2006 Nov 01; 76(11):1002-6. PubMed ID: 17054550 [Abstract] [Full Text] [Related]
18. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast. Broekhuizen LN, Wijsman JH, Peterse JL, Rutgers EJ. Eur J Surg Oncol; 2006 Jun 01; 32(5):502-6. PubMed ID: 16569492 [Abstract] [Full Text] [Related]
19. Axillary lymphectomy in breast cancer. Barillari P, Leuzzi R, D'Angelo F, Bassiri-Gharb A, Naticchioni E. Minerva Chir; 2002 Apr 01; 57(2):129-33. PubMed ID: 11941288 [Abstract] [Full Text] [Related]
20. CD44 expression and axillary lymph node metastasis in infiltrating ductal carcinoma of the breast. Looi LM, Cheah PL, Zhao W, Ng MH, Yip CH. Malays J Pathol; 2006 Dec 01; 28(2):83-6. PubMed ID: 18376796 [Abstract] [Full Text] [Related] Page: [Next] [New Search]